Evolution and structure of clinically relevant gene fusions in multiple myeloma
Multiple myeloma is characterised by frequent gene fusions. Here, the authors use data from the Multiple Myeloma Research Foundation CoMMpass Study to further investigate fusion genes in this disease and their clinical relevance.
Main Authors: | Steven M. Foltz, Qingsong Gao, Christopher J. Yoon, Hua Sun, Lijun Yao, Yize Li, Reyka G. Jayasinghe, Song Cao, Justin King, Daniel R. Kohnen, Mark A. Fiala, Li Ding, Ravi Vij |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16434-y |
Similar Items
-
Co-evolution of tumor and immune cells during progression of multiple myeloma
by: Ruiyang Liu, et al.
Published: (2021-05-01) -
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
by: Jennifer Sun, et al.
Published: (2020-01-01) -
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma
by: Yunlu Jia, et al.
Published: (2021-02-01) -
Targeted treatments for multiple myeloma: specific role of carfilzomib
by: Sugumar D, et al.
Published: (2015-01-01) -
Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance
by: Chen HF, et al.
Published: (2012-11-01)